Literature DB >> 7930496

Definition and differential diagnosis of treatment-resistant depression.

G D Burrows1, T R Norman, F K Judd.   

Abstract

There are no agreed criteria for treatment-resistant depression, but the failure to respond adequately to two successive courses of monotherapy with pharmacologically different antidepressants, given in an adequate dose for sufficient time is one pragmatic definition. Inherent within this definition are notions of what constitutes an adequate dose of drug, the length of treatment and pharmacological specificity of treatments. When these factors are accounted for, treatment resistance may be encountered in 15-20% of patients. In attempting to treat such patients a number of pharmacological strategies have been adopted and some are briefly reviewed. Psychosurgery may have a role to play in cases of absolute treatment resistance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930496     DOI: 10.1097/00004850-199406002-00002

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  7 in total

Review 1.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 2.  Illuminating rationale and uses for light therapy.

Authors:  Afshin Shirani; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

3.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

4.  Mirtazapine for treatment-resistant depression: a preliminary report.

Authors:  Dante D C Wan; Divya Kundhur; Kevin Solomons; Lakshmi N Yatham; Raymond W Lam
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 5.  Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Authors:  I Schweitzer; V Tuckwell
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 6.  A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.

Authors:  Jeremy D Coplan; Srinath Gopinath; Chadi G Abdallah; Benjamin R Berry
Journal:  Front Behav Neurosci       Date:  2014-05-20       Impact factor: 3.558

7.  Zinc Deficiency Blunts the Effectiveness of Antidepressants in the Olfactory Bulbectomy Model of Depression in Rats.

Authors:  Anna Rafało-Ulińska; Bartłomiej Pochwat; Paulina Misztak; Ryszard Bugno; Agata Kryczyk-Poprawa; Włodzimierz Opoka; Bożena Muszyńska; Ewa Poleszak; Gabriel Nowak; Bernadeta Szewczyk
Journal:  Nutrients       Date:  2022-06-30       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.